Jim Horhey

Doctor of Osteopathic Medicine,  The Johns Hopkins Hospital 

Location: Germany

Consulting Services

Biostatistics Hospital-Pharmacy-Insurance IT-Web-Mobile Technology

Areas Of Interest

Eating Behavior Pigeon, Domestic Bradykinin B1 Receptor Blockers CXCL6, Chemokine Bilharziasis Degenerative Diseases, Spinal Cord Desoxycholic Acid ADP ATP Carrier Protein, Liver Isoform T2 Protein Folding Diseases Crop Protection Type 1 Collagen Collagen, Type X Anociassociation Committee, Advisory Drug Effects on Physiology Salamanders, Mole Brain Hemorrhages, Cerebral Retrobulbar Hemorrhages Plagiocephaly, Synostotic Posterior Sch-32088 Uveitis, Intermediate Synaptotagmins Hermansky-Pudlak Syndrome 7 Protein Aminoacylation, Transfer RNA Semi Permeable Chambers Biphasic Intermittent Positive Airway Pressure gilletius, Zanthoxylum

Professional Narrative

Dr. Jim Horhey was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Horhey has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Director Medicine, Harvard Med 2001
Senior Director, Mayo Clinic 2010

Education

Bachelor of science in nursing, Perelman School of Medicine 2006
Master of Science in physician assistant, Yale School of Medicine 2005

Referees


Publications

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :